SCHEMBL794524

SCHEMBL794524

Cc1n[nH]c2cc(C3=NN(c4cc(C(F)(F)F)cc(C(F)(F)F)c4)Cc4ccccc43)ccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 6/20 0.34
DDR2 Q16832 6/20 0.34
PAK1 Q13153 1/20 0.33
METAP2 P50579 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
TRPA1 O75762 2/20 0.33
MAP2K4 P45985 2/20 0.32
SCN5A Q14524 1/20 0.32
SCN9A Q15858 1/20 0.32
GSK3B P49841 1/20 0.32
MAPK1 P28482 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK6 Q16659 1/20 0.31
MAPKAPK5 Q8IW41 1/20 0.31
AXL P30530 1/20 0.31
KDR P35968 1/20 0.31
EPHB4 P54760 1/20 0.31
TEK Q02763 1/20 0.31
MKNK1 Q9BUB5 1/20 0.31
MKNK2 Q9HBH9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12907442 0.70 TRPA1 (0.60) TRPV1TRPA1SCN5ASCN9AMAPK1
SCHEMBL12907422 0.69 GSK3B (0.55) FGFR1TRPA1MAP2K4GSK3BMAPK1
SCHEMBL12907428 0.69 HDAC1 (0.51) TRPA1MAP2K4GSK3BMAPK1MAPK6
SCHEMBL787674 0.69 ALDH1A1 (0.43) ALDH1A1
SCHEMBL13122227 0.66 TRPA1 (0.55) METAP2TRPA1MAP2K4SCN5AGSK3B
SCHEMBL794078 0.64 MAPT (0.50) MAP2K4KDR
SCHEMBL12907457 0.64 JAK2 (0.67) FGFR1MAP2K4GSK3BAXLKDR
SCHEMBL12907427 0.63 QPCT (0.49) FGFR1PAK1METAP2GSK3BKDR
SCHEMBL18387882 0.61 AXL (0.41) FGFR1PAK1GSK3BAXL
Bromide SCHEMBL15365106 0.61 ALDH1A1 (0.61) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616443-A1 PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS Exelixis, Inc. (US) 2013-07-24 EP disclosed
WO-2012037132-A1 PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS EXELIXIS, INC. (US) 2012-03-22 WO disclosed